Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Apr, 25 2025
Sep, 26 2025
Dec, 15 2025
Oct, 3 2025
Mar, 3 2026